We further measured mRNA expression of the SRGN gene using RT–PCR in tissues from 106 cases of TNBC and 320 cases of other BC types (non-TNBC) and we found that TNBC tumors contained significantly higher SRGN mRNA levels compared with other BC types (P<0.001, Figure 1d). This evidence concerns the gene SRGN and breast cancer.